October 29, 2024 | clinical research, clinical trials, patient recruitment
Innovative Trials has been named the second-fastest-growing, women-powered UK company in clinical research and ranks among the top 200 women-powered businesses in the UK!

Innovative Trials has been named the second-fastest-growing, women-powered UK company in clinical research and ranks among the top 200 women-powered businesses in the UK! This recognition by J.P. Morgan highlights Innovative Trials’ commitment to championing opportunities for women and driving patient-centric clinical trial recruitment and retention strategies.
Read the full press release 👉 https://bit.ly/3Uq5QNl
This content was provided by Innovative Trials
Company Details
Latest Content from Innovative Trials
Kate Shaw, founder and CEO of Innovative Trials, a global clinical trial patient recruitment and retention company, won the ‘Woman in Pharma’ at the Pharma Industry Awards UK. She was…
Patient recruitment company, Innovative Trials, has been nominated as a finalist in 2 categories at the Pharma Industry Award Read the full press release 👉🏽 https://bit.ly/3MdzBwf
Join the upcoming webinar which will discuss key patient recruitment & retention challenges and solutions for upcoming influenza studies.
This white paper explores the importance of patient-first services and why direct patient support is crucial for the success of sponsors’ clinical trials. Download it for FREE 👉🏽 https://innovativetrials.com/six-reasons-why-direct-patient-support-is-a-must-have-for-your-clinical-trials/
Step into the realm of innovation and collaboration in patient recruitment and retention with our upcoming webinar, “Bridging Boundaries: Uniting Communities for Rare Disease Clinical Trial Success.” Delve deep into…
In the landscape of the clinical trial industry in 2024, persistent challenges persist in the realms of patient recruitment and retention. These hurdles, having endured over several years, continue to…
Clinical trial patient recruitment and retention remains one of the key challenges to successfully bringing a new therapeutic to market. An estimated 85% of clinical trials face delays due to…
Innovative Trials, a global patient recruitment and retention company, has just announced GOSH Charity and Oliver Patch Project as their charity partners of the year
Join this live webinar focusing on patient recruitment and retention in rare disease trials.
A partnership between Innovative Trials and the non-profit Oliver Patch Project to boost retention in pediatric studies
